These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23386900)

  • 21. Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs.
    Tannenbaum CS; Rayman PA; Pavicic PG; Kim JS; Wei W; Polefko A; Wallace W; Rini BI; Morris-Stiff G; Allende DS; Hamilton T; Finke JH; Diaz-Montero CM
    Cancer Immunol Res; 2019 Oct; 7(10):1687-1699. PubMed ID: 31439615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production.
    Netherby CS; Messmer MN; Burkard-Mandel L; Colligan S; Miller A; Cortes Gomez E; Wang J; Nemeth MJ; Abrams SI
    J Immunol; 2017 May; 198(10):4129-4139. PubMed ID: 28356386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.
    Bruno A; Mortara L; Baci D; Noonan DM; Albini A
    Front Immunol; 2019; 10():771. PubMed ID: 31057536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative.
    Karin N
    Front Immunol; 2020; 11():557586. PubMed ID: 33193327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid cell population dynamics in healthy and tumor-bearing mice.
    Ueha S; Shand FH; Matsushima K
    Int Immunopharmacol; 2011 Jul; 11(7):783-8. PubMed ID: 21406269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond.
    Pastaki Khoshbin A; Eskian M; Keshavarz-Fathi M; Rezaei N
    Arch Immunol Ther Exp (Warsz); 2019 Apr; 67(2):89-102. PubMed ID: 30386868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid-derived suppressor cells: Bridging the gap between inflammation and pancreatic adenocarcinoma.
    Sharma V; Aggarwal A; Jacob J; Sahni D
    Scand J Immunol; 2021 May; 93(5):e13021. PubMed ID: 33455004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the Neutrophil in the Pathogenesis of Advanced Cancer and Impaired Responsiveness to Therapy.
    Rapoport BL; Steel HC; Theron AJ; Smit T; Anderson R
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32244751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.
    Mohamed E; Sierra RA; Trillo-Tinoco J; Cao Y; Innamarato P; Payne KK; de Mingo Pulido A; Mandula J; Zhang S; Thevenot P; Biswas S; Abdalla SK; Costich TL; Hänggi K; Anadon CM; Flores ER; Haura EB; Mehrotra S; Pilon-Thomas S; Ruffell B; Munn DH; Cubillos-Ruiz JR; Conejo-Garcia JR; Rodriguez PC
    Immunity; 2020 Apr; 52(4):668-682.e7. PubMed ID: 32294407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy.
    Innamarato P; Kodumudi K; Asby S; Schachner B; Hall M; Mackay A; Wiener D; Beatty M; Nagle L; Creelan BC; Sarnaik AA; Pilon-Thomas S
    Mol Ther; 2020 Oct; 28(10):2252-2270. PubMed ID: 32615068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells.
    Xiao P; Wan X; Cui B; Liu Y; Qiu C; Rong J; Zheng M; Song Y; Chen L; He J; Tan Q; Wang X; Shao X; Liu Y; Cao X; Wang Q
    Oncoimmunology; 2016; 5(1):e1063772. PubMed ID: 26942079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients.
    Van Wigcheren GF; De Haas N; Mulder TA; Horrevorts SK; Bloemendal M; Hins-Debree S; Mao Y; Kiessling R; van Herpen CML; Flórez-Grau G; Hato SV; De Vries IJM
    Oncoimmunology; 2021; 10(1):1935557. PubMed ID: 34239773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloid-Derived Suppressor Cells: Ductile Targets in Disease.
    Consonni FM; Porta C; Marino A; Pandolfo C; Mola S; Bleve A; Sica A
    Front Immunol; 2019; 10():949. PubMed ID: 31130949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.
    Finke J; Ko J; Rini B; Rayman P; Ireland J; Cohen P
    Int Immunopharmacol; 2011 Jul; 11(7):856-61. PubMed ID: 21315783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells.
    Bianchi G; Borgonovo G; Pistoia V; Raffaghello L
    Histol Histopathol; 2011 Jul; 26(7):941-51. PubMed ID: 21630223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myeloid-derived suppressor cells in malignant melanoma.
    Umansky V; Sevko A; Gebhardt C; Utikal J
    J Dtsch Dermatol Ges; 2014 Nov; 12(11):1021-7. PubMed ID: 25263083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid-derived suppressor cells: The green light for myeloma immune escape.
    Malek E; de Lima M; Letterio JJ; Kim BG; Finke JH; Driscoll JJ; Giralt SA
    Blood Rev; 2016 Sep; 30(5):341-8. PubMed ID: 27132116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of myeloid-derived suppressor cells (MDSC) in the inflammaging process.
    Salminen A; Kaarniranta K; Kauppinen A
    Ageing Res Rev; 2018 Dec; 48():1-10. PubMed ID: 30248408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloid suppressor cells in cancer and autoimmunity.
    Sica A; Massarotti M
    J Autoimmun; 2017 Dec; 85():117-125. PubMed ID: 28728794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.